998MO Nivolumab and ipilimumab combination treatment in advanced dMMR/MSI-H noncolorectal cancers: Results from the phase II MoST-CIRCUIT studyOliver Klein, M.S. Carlino, Henry Chan et al.|Annals of Oncology|2024Cited by 1